Allogene Therapeutics Inc at TD Cowen Healthcare Conference Transcript
Good morning everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen. Thank you very much for joining TD Cowen's, 46th Annual Healthcare Conference. For our next session, we have a presentation, hybrid presentation and fireside chat with Allogene, and it's my pleasure to introduce the David Chang, President and CEO and Co-founder of Allogene, and the Zach Roberts, Executive Vice President, R&D, and Chief Medical Officer. David and Zach, thank you so much for joining me. David, I'll hand it over to you for the presentation.
Yeah. Thanks, Tyler, for that introduction. You know, I don't know about putting "the" in front of names, but anyway, I really appreciate inviting us to this exciting conference, except the weather. What we'll be doing is a little bit of a hybrid presentation just to orient everybody about where Allogene is. We've been advancing the Allogene XL therapy for past eight years. When we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
